Tina Esfandiary

Massachusetts Institute of Technology

Papers

1

Total Citations

52

H-Index

1

About

Tina Esfandiary is a biomedical engineer whose research lies at the intersection of drug delivery, tissue engineering, and automated laboratory systems. Her most impactful work, "Robotically handled whole-tissue culture system for the screening of oral drug formulations" (2020), has garnered 52 citations and represents a significant advance in preclinical drug testing. In this study, Esfandiary pioneered a robotic platform that maintains living oral tissue in culture, enabling high-throughput, physiologically relevant screening of oral drug formulations without the need for animal models. This innovation addresses a critical bottleneck in pharmaceutical development, where traditional cell-based assays often fail to predict in vivo behavior. By integrating robotics with tissue culture, her work reduces variability, increases reproducibility, and accelerates the identification of promising drug candidates. Esfandiary’s contributions are particularly notable for bridging engineering and pharmacology, offering a scalable solution that could transform how oral medications are tested before clinical trials. Her research has been recognized for its potential to reduce animal testing and improve drug development efficiency, marking her as a rising leader in automated tissue engineering and drug screening.

Research Focus

Key Achievements

1
H-Index
1
Papers
52
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
Robotically handled whole-tissue culture system for the screening of oral drug formulations
52 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Massachusetts Institute of Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago